Related Experiment Video
Updated: Aug 14, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Post-PCI Risk Assessment by Inflammation Activity According to Disease Acuity and Time from Procedure
Haegeun Song1,2, Jong-Hwa Ahn3, Min Gyu Kang4,5
1Division of Cardiology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, South Korea.
Insights
Acute myocardial infarction (AMI) patients show higher inflammation than non-AMI patients. Early high-sensitivity C-reactive protein (hs-CRP) predicts outcomes in AMI, while later hs-CRP predicts outcomes in both AMI and non-AMI patients.
Area of Science:
- Cardiology
- Biomarkers
- Inflammation Research
Background:
- High-sensitivity C-reactive protein (hs-CRP) is a marker for inflammation and cardiovascular disease risk.
- Limited data exists on the temporal profile of hs-CRP and its association with outcomes based on disease acuity.
Purpose of the Study:
- To investigate the temporal profile of hs-CRP in patients undergoing percutaneous coronary intervention (PCI).
- To evaluate the relationship between hs-CRP levels and major adverse cardiovascular events (MACE) in patients with acute myocardial infarction (AMI) versus stable coronary artery disease.
Main Methods:
- A cohort of 4,263 East Asian patients undergoing PCI for AMI or stable disease was studied.
- hs-CRP levels were measured at baseline and 1 month post-PCI.
- Patients were followed for up to 4 years for MACE (death, myocardial infarction, stroke) and major bleeding.
Main Results:
- AMI patients exhibited higher baseline and 1-month post-PCI hs-CRP levels compared to non-AMI patients (p < 0.001).
- Elevated baseline hs-CRP (≥ 2.4 mg/L) predicted higher MACE within 1 month only in the AMI group (aHR: 7.66).
- Elevated 1-month hs-CRP (≥ 1.6 mg/L) predicted higher MACE between 1 month and 4 years in both AMI (aHR: 2.40) and non-AMI groups (aHR: 2.67).
Conclusions:
- Patients with AMI experience heightened inflammation in both early and late post-PCI phases compared to non-AMI patients.
- Baseline hs-CRP is a significant predictor of short-term outcomes exclusively in AMI patients.
- The prognostic value of hs-CRP for long-term outcomes is comparable between AMI and non-AMI patients.
Background:
High-sensitivity C-reactive protein (hs-CRP) has been proposed as an indicator of inflammation and cardiovascular risk. However, little is known of the comparative temporal profile of hs-CRP and its relation to outcomes according to the disease acuity.
Methods:
We enrolled 4,263 East Asian patients who underwent percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) and stable disease. hs-CRP was measured at baseline and 1 month post-PCI. Major adverse cardiovascular events (MACE: the composite occurrence of death, myocardial infarction, or stroke) and major bleeding were followed up to 4 years.
Result:
The AMI group (n = 2,376; 55.7%) had higher hs-CRPbaseline than the non-AMI group (n = 1,887; 44.3%) (median: 1.5 vs. 1.0 mg/L; p < 0.001), which remained higher at 1 month post-PCI (median: 1.0 vs. 0.9 mg/L; p = 0.001). During 1 month, a high inflammatory-risk phenotype (upper tertile: hs-CRPbaseline ≥ 2.4 mg/L) was associated with a greater MACE in the AMI group (adjusted hazard ratio [HRadj]: 7.66; 95% confidence interval [CI]: 2.29-25.59; p < 0.001), but not in the non-AMI group (HRadj: 0.74; 95% CI: 0.12-4.40; p = 0.736). Between 1 month and 4 years, a high inflammatory-risk phenotype (upper tertile: hs-CRP1 month ≥ 1.6 mg/L) was associated with greater MACE compared to the other phenotype in both the AMI (HRadj: 2.40; 95% CI: 1.73-3.45; p < 0.001) and non-AMI groups (HRadj: 2.67; 95% CI: 1.80-3.94; p < 0.001).
Conclusion:
AMI patients have greater inflammation during the early and late phases than non-AMI patients. Risk phenotype of hs-CRPbaseline correlates with 1-month outcomes only in AMI patients. However, the prognostic implications of this risk phenotype appears similar during the late phase, irrespective of the disease acuity.
More Related Videos
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care

